-
Iris neovascularization at the pupillary margin noted by the arrow.
-
Neovascularization noted near and into the inferotempral angle.
-
Fluorescein angiography (FA) of the iris and goniscopic FA showing significant NVI on iris plane (C) and in the angle (D).
-
Fluorescein angiography (FA) of the iris and goniscopic FA showing significant NVI on iris plane (C) and in the angle (D).
-
Ciliary flush, severe iris and lenticular neovascularization.
-
Same
patient with layered hyphema noted in the
inferior angle.
-
Patient with retinal arterial
occlusive disease; note retinal whitening
superior to macula and occluded (ghosted)
inferotemporal vessels.
-
Angiography
shows remarkable non-perfusion.
-
Angiographic leakage of nvi is seen here.
-
Fundus
photograph of patient
with proliferative diabetic
retinopathy previously
well treated with
panretinal photocoagulation.
-
Fluorescein
angiography demonstrates
active neovascularization
of the disc
and the iris
-
Fluorescein
angiography demonstrates
active neovascularization
of the disc
and the iris
-
An 81-year-old white male with chronic total occlusion of internal carotid artery
on the right side and moderate occlusion of the left side. At the time of examination images
shown here, VA OD: CF@4’ OS: 20/50 IOP OD: 24 OS: 13 (Patient was on Travatan
[travoprost, Alcon] qhs OD).
-
A and D show some signs of retinal arterial-occlusive disease,
including the peripheral Hollenhorst plaque (E). Fluorescein angiography (FA) OD shows
significant retinal ischemic disease (B) with severe NVI (C). Although left eye retinal angiogram
is not very impressive, (F) the iris shows significant neovascularization at the pupillary
margin (G).
-
A and D show some signs of retinal arterial-occlusive disease,
including the peripheral Hollenhorst plaque (E). Fluorescein angiography (FA) OD shows
significant retinal ischemic disease (B) with severe NVI (C). Although left eye retinal angiogram
is not very impressive, (F) the iris shows significant neovascularization at the pupillary
margin (G).
-
A and D show some signs of retinal arterial-occlusive disease,
including the peripheral Hollenhorst plaque (E). Fluorescein angiography (FA) OD shows
significant retinal ischemic disease (B) with severe NVI (C). Although left eye retinal angiogram
is not very impressive, (F) the iris shows significant neovascularization at the pupillary
margin (G).
-
A and D show some signs of retinal arterial-occlusive disease,
including the peripheral Hollenhorst plaque (E). Fluorescein angiography (FA) OD shows
significant retinal ischemic disease (B) with severe NVI (C). Although left eye retinal angiogram
is not very impressive, (F) the iris shows significant neovascularization at the pupillary
margin (G).
-
A and D show some signs of retinal arterial-occlusive disease,
including the peripheral Hollenhorst plaque (E). Fluorescein angiography (FA) OD shows
significant retinal ischemic disease (B) with severe NVI (C). Although left eye retinal angiogram
is not very impressive, (F) the iris shows significant neovascularization at the pupillary
margin (G).
-
A and D show some signs of retinal arterial-occlusive disease, including the peripheral Hollenhorst plaque (E). Fluorescein angiography (FA) OD shows significant retinal ischemic disease (B) with severe NVI (C). Although left eye retinal angiogram is not very impressive, (F) the iris shows significant neovascularization at the pupillary margin (G).
-
A 55-year-old white female presented with recent onset eye pain OS and vision
loss for approximately one month. She had light perception (LP) vision, with IOP of 40 mm
Hg. Other remarkable findings were iris neovascularization, significant opacification of the
lens, and retorlenticular space
-
She has a total retinal detachment (RD ) with a suspicious
but inconclusive B-scan
-
Repair of the RD was attempted by pars plana lensectomy,
vitrectomy, and use of silicone oil. Intra- and post operatively, the patient was noted to
have a large central mass
-
The retina is under silicone oil; large pigmented central mass
obscures the optic nerve and macula. The lesion was subsequently confirmed as a malignant
melanoma and, due to poor visual outcome and high systemic risk, patient underwent an
enucleation.
-
Angiography showing active
neovascularization of the disc and iris
-
One week following treatment with
intravitreous injection of Avastin (bevacizumab,
Genentech), significant regression
of neovascularization is noted (C,D).
-
One week following treatment with
intravitreous injection of Avastin (bevacizumab,
Genentech), significant regression
of neovascularization is noted (C,D).
-
One week following treatment with
intravitreous injection of Avastin (bevacizumab,
Genentech), significant regression
of neovascularization is noted (C,D).